3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
2
Rhabdomyosarcoma
2
Ovarian Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Stomach Neoplasms
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Adenocarcinoma
1
Interventions
Oxaliplatin
3
Cisplatin
3
pembrolizumab
2
Leucovorin
2
Irinotecan
2
Gemcitabine
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Carboplatin
2
umbralisib
1
sodium thiosulfate
1
motexafin lutetium
1
montanide ISA 51
1
entinostat
1
ciforadenant
1
cediranib
1
X-Rays
1
Thalidomide
1
Standard of Care
1
Specimen Handling
1
Serotonin Plasma Membrane Transport Proteins
1
Ritonavir
1
Radiotherapy
1
Radiosurgery
1
Radionuclide Imaging
1
Quality of Life
1
Psychology, Positive
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Cytoreduction Surgical Procedures
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled